NIH-funded research R01 grant

How chemical marks on RNA in fat tissue affect metabolism and obesity

Official title: Role of adipose mRNA modifications in metabolic disease

Funded at University of Michigan at Ann Arbor · NIH-11292850 · Data updated 2026-11-12

Researchers are looking at whether reversible chemical marks on RNA in fat cells change how fat grows and signals, with the aim of helping people with obesity and metabolic problems.

More Metabolic Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startMarch 1, 2022
Project endFebruary 28, 2027
Funding year2026
Award (this year)$474,240
NIH project number5R01DK130111-05
Project IDNIH-11292850 on NIH RePORTER

Who could benefit from this research

Could help

People with obesity or metabolic syndrome would be the eventual patient groups most likely to benefit from therapies based on this work, although the current work is preclinical.

Less likely to help

Patients without obesity-related metabolic problems, or those seeking immediate clinical treatments, are unlikely to benefit directly from this laboratory-based project.

What this research studies

This project studies a specific RNA modification called m6A in fat (adipose) tissue and how it controls fat cell function and hormone signals. The team uses genetically engineered mice that lack key RNA-modifying proteins in fat cells to see how those changes affect weight gain, adipokine secretion, and whole-body metabolism. They combine molecular lab work on fat cells, sequencing and biochemical assays, and viral delivery tools to modify RNA pathways in adipose tissue. Findings are intended to point to molecular targets that could be tested later in treatments for obesity-related metabolic disease.

Why it matters

Potential benefit: If successful, the work could reveal new molecular ways to change fat behavior or signals that lead to treatments to prevent or improve obesity and its complications.

How similar studies have gone: Some prior studies have linked m6A RNA modifications to metabolism, but applying m6A-focused approaches specifically to adipose tissue and obesity is novel and early-stage.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Rui, Liangyou — University of Michigan at Ann Arbor
  • Study coordinator: Rui, Liangyou

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.